Optimistic planning, or at least judicious timing, would be necessary to take advantage of the drugs effects
Background: From GHRP-2 / GHRP-6 to Ipamorelin & CJC-1295 GHRP-2 and GHRP-6 were among the first peptides used to enhance growth hormone release
With each hypoglycemic episode, more cells are damaged
The risks depend, among other factors, on which product was used, where it was injected, how deeply it was injected, whether sterile technique was used and whether there are underlying medical conditions or medications
In addition, online products do not undergo the same premarket review and manufacturing controls as approved medicines
no KLOW trial Community approach Extended cycle Reported duration 8-12 weeks Reported break About 4 weeks Evidence level Reported in community protocols